| Effect of food on the bioavailability of gepirone in humans. | |
| | |
MedLine Citation:
|
PMID: 8103528 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A randomized two-period crossover study was conducted in 20 healthy male volunteers to assess the effect of food on the pharmacokinetics of gepirone (BMY-13805) and its metabolite, 1-(2-pyrimidinyl)-piperazine (1-PP) after a single 20-mg dose of gepirone either after fasting or after consumption of a standard high-fat breakfast. There was a 1-week washout period between treatments. Plasma samples were obtained predose and at specified time points after dosing and analyzed for gepirone and 1-PP content by a specific gas chromatographic-mass spectrometric method. Food did not significantly affect gepirone maximum peak plasma concentration (Cmax) and half-life (t1/2). The mean gepirone Cmax was 16.98 +/- 8.12 ng/mL (fed) and 18.73 +/- 10.30 ng/mL (fasted), with mean t1/2 of 3.32 +/- 1.84 hours (fed) and 2.94 +/- 0.90 hours (fasted). Food significantly increased the mean area under the curveinf (AUCinf) from 55.26 +/- 35.74 ng.hour/mL (fasted) to 75.69 +/- 42.79 ng.hour/mL (fed), and the mean residence timeinf (MRTinf) from 4.31 +/- 0.78 hours (fasted) to 5.37 +/- 1.21 hours (fed). The median time to maximum plasma concentration (tmax) for gepirone was also significantly increased in the presence of food, 2.0 hours, versus 0.75 hours in the absence of food. For 1-PP, food had no affect on Cmax, t1/2, or AUCinf. Mean t1/2 for 1-PP in the presence and absence of food was 6.06 +/- 1.75 and 5.76 +/- 1.75 hours, respectively. MRTinf, however, was increased significantly from 9.32 +/- 2.68 hours (fasted) to 10.53 +/- 2.89 hours (fed).(ABSTRACT TRUNCATED AT 250 WORDS) |
| | |
Authors:
|
L K Tay; M A Sciacca; M B Sostrin; R H Farmen; K A Pittman |
Related Documents
:
|
19035558 - The influence of postharvest processing and storage of foodstuffs on the bioavailabilit... 8192698 - Study on the influence of food on the absorption of theophylline from a controlled-rele... 17953718 - Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in hea... 11269568 - Abacavir/lamivudine/zidovudine as a combined formulation tablet: bioequivalence compare... 10834188 - Development of process equipment to separate nonthermal and thermal effects of rf energ... 11883918 - Attitudes towards meat and meat-eating among adolescents in norway: a qualitative study. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Journal of clinical pharmacology Volume: 33 ISSN: 0091-2700 ISO Abbreviation: J Clin Pharmacol Publication Date: 1993 Jul |
Date Detail:
|
Created Date: 1993-10-07 Completed Date: 1993-10-07 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0366372 Medline TA: J Clin Pharmacol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 631-5 Citation Subset: IM |
Affiliation:
|
Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Co., Syracuse, New York 13221-4755. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Oral Adolescent Adult Anti-Anxiety Agents / pharmacokinetics* Antidepressive Agents / pharmacokinetics* Biological Availability Buspirone / analogs & derivatives, blood, pharmacokinetics Fasting / blood Food* Humans Male Pyrimidines / administration & dosage, blood, pharmacokinetics* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Anxiety Agents; 0/Antidepressive Agents; 0/Pyrimidines; 20980-22-7/1-(2-pyrimidinyl)piperazine; 36505-84-7/Buspirone; 83928-76-1/gepirone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertens...
Next Document: Innervation of the monotreme gastrointestinal tract: a study of peptide and catecholamine distributi...